Center for Scientific Review; Notice of Closed Meetings, 70522-70523 [06-9527]
Download as PDF
<![CDATA[
ycherry on PROD1PC64 with NOTICES
70522
Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, Brain Trauma & Imaging.
Date: December 11, 2006.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852. (Telephone
Conference Call).
Contact Person: Richard D. Crosland, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
MSC 9529, Bethesda, MD 20892–9529. 301–
594–0635. rc218u@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, Cognition and Imaging.
Date: December 18, 2006.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852. (Telephone
Conference Call).
Contact Person: Richard D. Crosland, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3208,
MSC 9529, Bethesda, MD 20892–9529. 301–
594–0635.rc218u@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel, Epilepsy Clinical Trial.
Date: December 20, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Katherine Woodbury, PhD,
Scientific Review Administrator, Scientific
Review Branch, NINDS/NIH/DHHS,
Neuroscience Center, 6001 Executive Blvd.,
Suite 3208, MSC 9529, Bethesda, MD 20892–
9529. 301–496–5980. kw47o@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
VerDate Aug<31>2005
15:14 Dec 04, 2006
Jkt 211001
Dated: November 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9529 Filed 12–4–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Vitamin D
and Colon Cancer.
Date: December 5, 2006.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Sally A. Mulhern, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198,
MSC 7804, Bethesda, MD 20892. (301) 435–
5877. mulherns@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Member
Conflict: Neurophysiology devices
Neuroprosthetics.
Date: December 13, 2006.
Time: 9 a.m. to 10 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Vinod Charles, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5196,
MSC 7846, Bethesda, MD 20892. (301) 435–
0902. charlesvi@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Review
Member Applications on Neurodegeneration.
Date: December 18, 2006.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Toby Behar, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4136,
MSC 7850, Bethesda, MD 20892. (301) 435–
4433. behart@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Continued
Development and Maintenance of Software.
Date: January 8, 2007.
Time: 8:45 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Watergate, 2650 Virginia
Avenue, NW., Washington, DC 20037.
Contact Person: Malgorzata Klosek, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188,
MSC 7849, Bethesda, MD 20892. (301) 435–
2211. klosekm@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Surgery,
Anesthesiology and Trauma Study Section.
Date: January 24–25, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Weihua Luo PhD, MD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114
MSC 7854, Bethesda, MD 20892. 301–435–
1170. luow@csr.nih.gov.
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group, Enabling Bioanalytical and
Biophysical Technologies Study Section.
Date: January 31–February 1, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Marriott, 299 Second
Street, San Francisco, CA 94105.
Contact Person: Vonda K. Smith, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4148,
MSC 7806, Bethesda, MD 20892. 301–435–
1789. smithvo@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\05DEN1.SGM
05DEN1
70523
Federal Register / Vol. 71, No. 233 / Tuesday, December 5, 2006 / Notices
Dated: November 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 06–9527 Filed 12–4–06; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
Project: Regulations to Implement
SAMHSA’s Charitable Choice
Statutory Provisions—42 CFR parts 54
and 54a (OMB No. 0930–0242)—
Revision
Section 1955 of the Public Health
Service Act (42 U.S.C. 300x–65), as
amended by the Children’s Health Act
of 2000 (Pub. L. 106–310) and Sections
581–584 of the Public Health Service
Act (42 U.S.C. 290kk et seq., as added
by the Consolidated Appropriations Act
(Pub. L. 106–554)), set forth various
provisions which aim to ensure that
religious organizations are able to
compete on an equal footing for Federal
funds to provide substance abuse
services. These provisions allow
religious organizations to offer
substance abuse services to individuals
without impairing the religious
character of the organizations or the
religious freedom of the individuals
who receive the services. The provisions
apply to the Substance Abuse
Prevention and Treatment Block Grant
(SAPT BG), to the Projects for
Assistance in Transition from
Homelessness (PATH) formula grant
program, and to certain Substance
Abuse and Mental Health Services
Administration (SAMHSA)
Responses
per
respondent
Number of
respondents
42 CFR Citation and purpose
discretionary grant programs (programs
that pay for substance abuse treatment
and prevention services, not for certain
infrastructure and technical assistance
activities). Every effort has been made to
assure that the reporting, recordkeeping
and disclosure requirements of the
proposed regulations allow maximum
flexibility in implementation and
impose minimum burden.
No changes are being made to the
regulations. This revision is for approval
of the annual checklists to be completed
by discretionary and PATH grantees to
provide the information required to be
reported by 42 CFR part 54a.8(d) and
54.8(e), respectively, and to ascertain
how they are implementing the
disclosure requirements of 54a.8(b) and
54.8(b), respectively. Information on
how States comply with the
requirements of 42 CFR part 54a was
approved by the Office of Management
and Budget (OMB) as part of the
Substance Abuse Prevention and
Treatment Block Grant FY 2005–2007
annual application and reporting
requirements approved under OMB
control number 0930–0080.
Hours per
response
Total hours
Part 54—States Receiving SAPT Block Grants and/or Projects for Assistance in Transition from Homelessness
Reporting:
96.122(f)(5) Annual report of activities the State undertook to comply
42 CFR Part 54 .....................................................................................
54.8(c)(4) Program participant notification to responsible unit of government regarding referrals to alternative service providers .....................
54.8(e) Annual report by PATH grantees on activities undertaken to
comply with 42 CFR Part 54 .................................................................
Disclosure:
54.8(b) Program participant notice to program beneficiaries of rights
to referral to an alternative service provider.
SAPT BG ..................................................................................................
PATH ........................................................................................................
Recordkeeping:
54.6(b) Documentation must be maintained to demonstrate significant
burden for program participants under 42 U.S.C. 300x–57 or 42
U.S.C. 290cc–33(a)(2) ..........................................................................
Part 54—Subtotal ..............................................................................
60
1
2
120
3
24
2.00
48
56
1
2.00
112
60
56
10
84
.05
.05
300
236
60
1
1.00
60
181
........................
........................
876
Part 54a—States, local governments and religious organizations receiving funding under Title V of the PHS Act for substance abuse
prevention and treatment services
ycherry on PROD1PC64 with NOTICES
Reporting:
54a.8(c)(1)(iv) Program participant notification to State or local government of a referral to an alternative provider .........................................
54a(8)(d) Program participant notification to SAMHSA of referrals .........
Disclosure:
54a.8(b) Program participant notice to program beneficiaries of rights to
referral to an alternative service provider .............................................
25
20
4
2
.083
.25
8
10
1,460
1
1.0
1,460
Part 54a—Subtotal ................................................................................
1,505
........................
........................
1,478
Total ...........................................................................................
1,686
........................
........................
2,354
VerDate Aug<31>2005
15:14 Dec 04, 2006
Jkt 211001
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
E:\FR\FM\05DEN1.SGM
05DEN1
]]>Agencies
[Federal Register Volume 71, Number 233 (Tuesday, December 5, 2006)]
[Notices]
[Pages 70522-70523]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-9527]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Vitamin D and Colon Cancer.
Date: December 5, 2006.
Time: 11 a.m. to 12 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892. (Telephone Conference Call).
Contact Person: Sally A. Mulhern, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6198, MSC 7804, Bethesda, MD
20892. (301) 435-5877. mulherns@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel Member Conflict: Neurophysiology devices Neuroprosthetics.
Date: December 13, 2006.
Time: 9 a.m. to 10 a.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Vinod Charles, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5196, MSC 7846, Bethesda, MD
20892. (301) 435-0902. charlesvi@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Review Member Applications on Neurodegeneration.
Date: December 18, 2006.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Toby Behar, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4136, MSC 7850, Bethesda, MD
20892. (301) 435-4433. behart@csr.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Continued Development and Maintenance of Software.
Date: January 8, 2007.
Time: 8:45 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: The Watergate, 2650 Virginia Avenue, NW., Washington, DC
20037.
Contact Person: Malgorzata Klosek, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188, MSC 7849, Bethesda, MD
20892. (301) 435-2211. klosekm@csr.nih.gov.
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group, Surgery, Anesthesiology and
Trauma Study Section.
Date: January 24-25, 2007.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW.,
Washington, DC 20007.
Contact Person: Weihua Luo PhD, MD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5114 MSC 7854, Bethesda, MD
20892. 301-435-1170. luow@csr.nih.gov.
Name of Committee: Biological Chemistry and Macromolecular
Biophysics Integrated Review Group, Enabling Bioanalytical and
Biophysical Technologies Study Section.
Date: January 31-February 1, 2007.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard Marriott, 299 Second Street, San Francisco, CA
94105.
Contact Person: Vonda K. Smith, PhD, Scientific Review
Administrator, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4148, MSC 7806, Bethesda, MD
20892. 301-435-1789. smithvo@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
[[Page 70523]]
Dated: November 28, 2006.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 06-9527 Filed 12-4-06; 8:45 am]
BILLING CODE 4140-01-M
